Blumenfeld J D, Sealey J E, Schlussel Y, Vaughan E D, Sos T A, Atlas S A, Müller F B, Acevedo R, Ulick S, Laragh J H
Cardiovascular Center, New York Hospital-Cornell University Medical Center, NY 10021.
Ann Intern Med. 1994 Dec 1;121(11):877-85. doi: 10.7326/0003-4819-121-11-199412010-00010.
To characterize the clinical and laboratory features of primary aldosteronism and to evaluate which diagnostic tests can discriminate surgically curable forms of this syndrome.
Retrospective analysis of the following data from 82 patients with primary aldosteronism: blood pressure, serum electrolytes, urinary aldosterone and electrolytes, computed tomographic scans, plasma renin and aldosterone before and during upright posture, atrial natriuretic peptide, and adrenal vein aldosterone and cortisol. Clinical outcomes assessed after treatment included blood pressure, serum electrolytes, and plasma renin activity.
Drug therapy was discontinued before diagnostic tests were done in 56 of 82 patients (34 with adenomas and 22 with hyperplasia). Compared with patients with hyperplasia, those with adenomas had higher systolic (184 mm Hg and 161 mm Hg, respectively; P < 0.001) and diastolic blood pressures (112 mm Hg and 105 mm Hg; P = 0.03), lower serum potassium levels (3.0 mmol/L and 3.5 mmol/L; P < 0.001), and higher serum CO2 (P = 0.001), atrial natriuretic peptide (P = 0.008), and urinary 18-methyl oxygenated cortisol metabolite levels (P = 0.02). In patients with adenomas, aldosterone secretion lateralized to one adrenal gland and did not increase during the postural stimulation test; preoperative urinary aldosterone levels were correlated with diastolic pressures (r = 0.58; P = 0.001). Hypertension was "cured" postoperatively in approximately 35% of patients with adenomas and those with hyperplasia (P > 0.2) but was "improved" more frequently in those with adenomas (P = 0.002). Cured patients from both groups were younger than those not cured (mean ages, 43 years and 54 years, respectively; P = 0.002) and had lower preoperative mean plasma renin activity (0.17 ng/mL per hour and 0.50 ng/mL per hour; P < 0.001). All patients with adenomas in whom aldosterone secretion lateralized were either cured or improved.
Of the 51 patients with primary aldosteronism who had adrenalectomy (43 patients with adenomas and 8 with hyperplasia), those most likely to be cured were younger and had lower plasma renin activity. In patients with adenomas who were cured or improved, aldosterone secretion was more likely to lateralize. Tests that distinguished adenomas from adrenal hyperplasia included the postural stimulation test, urinary excretion rates of 18-oxocortisol and 18-hydroxycortisol, and adrenal vein sampling.
描述原发性醛固酮增多症的临床和实验室特征,并评估哪些诊断测试可鉴别该综合征的手术可治愈形式。
对82例原发性醛固酮增多症患者的以下数据进行回顾性分析:血压、血清电解质、尿醛固酮和电解质、计算机断层扫描、立位前后的血浆肾素和醛固酮、心钠素以及肾上腺静脉醛固酮和皮质醇。治疗后评估的临床结局包括血压、血清电解质和血浆肾素活性。
82例患者中有56例(34例腺瘤患者和22例增生患者)在进行诊断测试前停用了药物治疗。与增生患者相比,腺瘤患者的收缩压(分别为184 mmHg和161 mmHg;P<0.001)和舒张压(112 mmHg和105 mmHg;P = 0.03)更高,血清钾水平更低(3.0 mmol/L和3.5 mmol/L;P<0.001),血清二氧化碳、心钠素(P = 0.008)和尿18-甲基氧化皮质醇代谢物水平更高(P = 0.02)。在腺瘤患者中,醛固酮分泌偏向一侧肾上腺,在体位刺激试验中不增加;术前尿醛固酮水平与舒张压相关(r = 0.58;P = 0.001)。腺瘤患者和增生患者中约35%的高血压患者术后“治愈”(P>0.2),但腺瘤患者中“改善”更为常见(P = 0.002)。两组治愈患者均比未治愈患者年轻(平均年龄分别为43岁和54岁;P = 0.002),术前平均血浆肾素活性更低(0.17 ng/mL每小时和0.50 ng/mL每小时;P<0.001)。所有醛固酮分泌偏向一侧的腺瘤患者均治愈或改善。
在51例行肾上腺切除术的原发性醛固酮增多症患者(43例腺瘤患者和8例增生患者)中,最有可能治愈的是年龄较轻且血浆肾素活性较低的患者。在治愈或改善的腺瘤患者中,醛固酮分泌更有可能偏向一侧。区分腺瘤与肾上腺增生的测试包括体位刺激试验、18-氧皮质醇和18-羟皮质醇的尿排泄率以及肾上腺静脉采血。